Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.
2.

Novel Drugs of Abuse: A Snapshot of an Evolving Marketplace.

Vandrey R, Johnson MW, Johnson PS, Khalil MA.

Adolesc Psychiatry (Hilversum). 2013 Apr;3(2):123-134.

3.

From divination to madness: features of acute intoxication with Salvia use.

Winslow M, Mahendran R.

Singapore Med J. 2014 Apr;55(4):e52-3.

4.

Perspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds.

Neelkantan N, Mikhaylova A, Stewart AM, Arnold R, Gjeloshi V, Kondaveeti D, Poudel MK, Kalueff AV.

ACS Chem Neurosci. 2013 Aug 21;4(8):1137-50. doi: 10.1021/cn400090q. Epub 2013 Aug 6. Review.

5.

Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects.

MacLean KA, Johnson MW, Reissig CJ, Prisinzano TE, Griffiths RR.

Psychopharmacology (Berl). 2013 Mar;226(2):381-92. doi: 10.1007/s00213-012-2912-9. Epub 2012 Nov 8.

6.

Déjà experiences in temporal lobe epilepsy.

Illman NA, Butler CR, Souchay C, Moulin CJ.

Epilepsy Res Treat. 2012;2012:539567. doi: 10.1155/2012/539567. Epub 2012 Mar 20.

7.

Behavioral effects and central nervous system levels of the broadly available κ-agonist hallucinogen salvinorin A are affected by P-glycoprotein modulation in vivo.

Butelman ER, Caspers M, Lovell KM, Kreek MJ, Prisinzano TE.

J Pharmacol Exp Ther. 2012 Jun;341(3):802-8. doi: 10.1124/jpet.112.193227. Epub 2012 Mar 20.

8.

Use of Salvia divinorum in a nationally representative sample.

Perron BE, Ahmedani BK, Vaughn MG, Glass JE, Abdon A, Wu LT.

Am J Drug Alcohol Abuse. 2012 Jan;38(1):108-13. doi: 10.3109/00952990.2011.600397. Epub 2011 Aug 11.

9.
10.

Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial.

Mendelson JE, Coyle JR, Lopez JC, Baggott MJ, Flower K, Everhart ET, Munro TA, Galloway GP, Cohen BM.

Psychopharmacology (Berl). 2011 Apr;214(4):933-9. doi: 10.1007/s00213-010-2103-5. Epub 2010 Dec 8.

11.

Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum.

Johnson MW, MacLean KA, Reissig CJ, Prisinzano TE, Griffiths RR.

Drug Alcohol Depend. 2011 May 1;115(1-2):150-5. doi: 10.1016/j.drugalcdep.2010.11.005. Epub 2010 Dec 4.

12.

College student use of Salvia divinorum.

Lange JE, Reed MB, Croff JM, Clapp JD.

Drug Alcohol Depend. 2008 Apr 1;94(1-3):263-6. Epub 2008 Jan 14.

Supplemental Content

Support Center